Literature DB >> 10544105

A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle.

M Nishizawa1, T Myojin, Y Nishino, Y Nakai, M Kamata, Y Aida.   

Abstract

Vpr, one of the accessory gene products of HIV-1, is a 96-residue protein with several functions. It is involved in import of the HIV-1 preintegration complex into the nucleus of nondividing cells, in cellular differentiation, inducing cell cycle arrest at the G(2)/M phase, in immune suppression, and in enhancement of replication of the virus. We found recently that Vpr interferes with the proliferation of mouse NIH3T3 fibroblasts but fails to arrest these cells in the G(2) phase. Thus, it seems possible that Vpr might retard cell proliferation via a novel pathway that is distinct from G(2) arrest. To elucidate the mechanism by which Vpr induces the retardation of cell growth, we developed a panel of expression vectors that encoded Vpr molecules with deletions of specific putative domains, namely, the first alpha-helical domain, the second alpha-helical domain, a leucine zipper-like domain, and an arginine-rich carboxy-terminal domain. These vectors were introduced into HeLa cells since expression of Vpr can induce G(2) arrest in such cells. A carboxy-terminally truncated form of Vpr, C81, which failed to induce G(2) arrest, led to the G(1) arrest and retained the ability to prevent cell proliferation. All the other mutant proteins had completely lost the capacity to induce G(2) arrest and to suppress growth. Substitutions of Ile/Leu for Pro at positions 60, 67, 74, and 81 within the leucine zipper-like domain of Vpr or of C81 revealed that Ile60, Leu67, and Ile74 play an important role in the C81-induced suppression of growth, while Ile74 and Ile81 were found to be indispensable for Vpr-induced G(2) arrest. Collectively, our results strongly suggest that Vpr can retard cell proliferation independently of G(2) arrest of the cell cycle. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544105     DOI: 10.1006/viro.1999.9905

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest.

Authors:  M Nishizawa; M Kamata; R Katsumata; Y Aida
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.

Authors:  M Kamata; Y Aida
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 4.  Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Authors:  Simon Henriet; Gaëlle Mercenne; Serena Bernacchi; Jean-Christophe Paillart; Roland Marquet
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

5.  Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages.

Authors:  Yuko Nitahara-Kasahara; Masakazu Kamata; Takuya Yamamoto; Xianfeng Zhang; Yoichi Miyamoto; Koho Muneta; Sayuki Iijima; Yoshihiro Yoneda; Yasuko Tsunetsugu-Yokota; Yoko Aida
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

6.  Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr.

Authors:  Eri Takeda; Tomoyuki Murakami; Go Matsuda; Hironobu Murakami; Tamotsu Zako; Mizuo Maeda; Yoko Aida
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

7.  The putative protein 6 of the severe acute respiratory syndrome-associated coronavirus: expression and functional characterization.

Authors:  Hua Geng; Yuet-Man Liu; Wai-Sing Chan; Anthony Wing-Ip Lo; Deborah Mun-Yee Au; Mary Miu-Yee Waye; Yuan-Yuan Ho
Journal:  FEBS Lett       Date:  2005-11-21       Impact factor: 4.124

8.  Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus.

Authors:  Khalid Amine Timani; Qingjiao Liao; Linbai Ye; Yingchun Zeng; Jing Liu; Yi Zheng; Li Ye; Xiaojun Yang; Kong Lingbao; Jingrong Gao; Ying Zhu
Journal:  Virus Res       Date:  2005-06-29       Impact factor: 3.303

9.  A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.

Authors:  Patricio Oyarzun; Manju Kashyap; Victor Fica; Alexis Salas-Burgos; Faviel F Gonzalez-Galarza; Antony McCabe; Andrew R Jones; Derek Middleton; Bostjan Kobe
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

10.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.